SEMPERFLO* Pain Management System in Inguinal Hernia Repair
A Prospective, Randomized, Exploratory Comparison of the SEMPERFLO* Pain Management System to a Commercially Available Pain Relief System in Subjects Undergoing Open Inguinal Hernia Repair
Sponsor: Ethicon, Inc.
Terminated
Market dynamics including other technologies made the project not viable.
Other terminated trials from Ethicon, Inc.
- Cancer of the Liver · Jun 2025
- Lung Neoplasms · Phase NA · Oct 2024
- Cancer of the Lung · Phase NA · Sep 2023
- Cancer of the Liver · Phase NA · Oct 2022
- CSF Leak · Phase PHASE3 · Sep 2021
More terminations from Ethicon, Inc.
Other Inguinal Hernia trials with similar outcome
A NA clinical study on Inguinal Hernia and Pain, this trial is terminated or withdrawn. The trial is conducted by Ethicon, Inc. and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ethicon, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .